Compounds > cyclosporine

cyclosporine and Parkinsonian Disorders

cyclosporine has been researched along with Parkinsonian Disorders in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (83.33)	29.6817
2010's	1 (16.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agrawal, S; Dixit, A; Patel, DK; Singh, A; Singh, D; Singh, MP; Tripathi, P	1
Akamatsu, Y; Fujimori, K; Kawagishi, N; Miyagi, S; Sato, A; Satomi, S; Sekiguchi, S	1
Lima, MA; Maradei, S; Maranhao Filho, P	1
Bhidayasiri, R; Ling, H	1
Bartus, RT; Borlongan, CV; Emerich, DF; Hoffer, BJ	1
Han, SY; Kim, HC; Park, SB; Suh, SJ	1

Other Studies

6 other study(ies) available for cyclosporine and Parkinsonian Disorders

Article	Year
Cyclosporine A and MnTMPyP Alleviate α-Synuclein Expression and Aggregation in Cypermethrin-Induced Parkinsonism. Molecular neurobiology, 2015, Volume: 52, Issue:3 Topics: alpha-Synuclein; Animals; Corpus Striatum; Cyclosporine; Dopaminergic Neurons; Metalloporphyrins; Mitochondria; Oxidative Stress; Parkinson Disease; Parkinsonian Disorders; Pyrethrins; Rats, Wistar; Substantia Nigra	2015
Parkinsonism during cyclosporine treatment in liver transplantation: an unusual case report. Transplantation proceedings, 2008, Volume: 40, Issue:8 Topics: Adult; Cyclosporine; Hepatitis C; Humans; Immunosuppressive Agents; Levodopa; Liver Cirrhosis; Liver Transplantation; Male; Parkinsonian Disorders; Treatment Outcome	2008
Cyclosporine-induced parkinsonism. Journal of neurology, 2009, Volume: 256, Issue:4 Topics: Antiparkinson Agents; Brain; Carbidopa; Cyclosporine; Fatal Outcome; Hematoma, Subdural; Humans; Immunosuppressive Agents; Leukemia, Lymphoid; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Parkinsonian Disorders; Stem Cell Transplantation	2009
Reversible Parkinsonism after chronic cyclosporin treatment in renal transplantation. Movement disorders : official journal of the Movement Disorder Society, 2009, Sep-15, Volume: 24, Issue:12 Topics: Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Middle Aged; Parkinsonian Disorders	2009
Bradykinin receptor agonist facilitates low-dose cyclosporine-A protection against 6-hydroxydopamine neurotoxicity. Brain research, 2002, Nov-29, Volume: 956, Issue:2 Topics: Adrenergic Agents; Animals; Behavior, Animal; Blood-Brain Barrier; Bradykinin; Calcineurin; Corpus Striatum; Cyclosporine; Disease Models, Animal; Drug Synergism; Immunohistochemistry; Male; Motor Activity; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptor, Bradykinin B2; Receptors, Bradykinin; Substantia Nigra; Tyrosine 3-Monooxygenase	2002
Parkinsonism during cyclosporine treatment in renal transplantation. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2002, Volume: 17, Issue:2 Topics: Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Parkinsonian Disorders	2002